These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19202078)

  • 21. Aging of the Suprachiasmatic Nucleus,
    Björk V
    Rejuvenation Res; 2021 Aug; 24(4):274-282. PubMed ID: 33573456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression.
    Liu RY; Zhou JN; Hoogendijk WJ; van Heerikhuize J; Kamphorst W; Unmehopa UA; Hofman MA; Swaab DF
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):314-22. PubMed ID: 10759187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease.
    Fernandez FX; Kaladchibachi S; Negelspach DC
    Exp Gerontol; 2021 May; 147():111258. PubMed ID: 33516909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interacting influences of aging and Alzheimer's disease on circadian rhythms.
    Duncan MJ
    Eur J Neurosci; 2020 Jan; 51(1):310-325. PubMed ID: 30689226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging.
    Hofman MA; Swaab DF
    Brain Res; 1994 Jul; 651(1-2):134-42. PubMed ID: 7922560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degeneration of the Suprachiasmatic Nucleus in an Alzheimer's Disease Mouse Model Monitored by in vivo Magnetic Resonance Relaxation Measurements and Immunohistochemistry.
    Roy U; Heredia-Muñoz MT; Stute L; Höfling C; Matysik J; Meijer JH; Roßner S; Alia A
    J Alzheimers Dis; 2019; 69(2):363-375. PubMed ID: 30958376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease.
    Wu YH; Zhou JN; Van Heerikhuize J; Jockers R; Swaab DF
    Neurobiol Aging; 2007 Aug; 28(8):1239-47. PubMed ID: 16837102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
    Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
    Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer's disease.
    Wu M; Zhou F; Cao X; Yang J; Bai Y; Yan X; Cao J; Qi J
    Neurosci Lett; 2018 May; 676():13-18. PubMed ID: 29626648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in the expression of Per1 and Per2 induced by Aβ31-35 in the suprachiasmatic nucleus, hippocampus, and heart of C57BL/6 mouse.
    Wang X; Wang L; Yu Q; Xu Y; Zhang L; Zhao X; Cao X; Li Y; Li L
    Brain Res; 2016 Jul; 1642():51-58. PubMed ID: 27021954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactive Effects of Dorsomedial Hypothalamic Nucleus and Time-Restricted Feeding on Fractal Motor Activity Regulation.
    Lo MT; Chiang WY; Hsieh WH; Escobar C; Buijs RM; Hu K
    Front Physiol; 2016; 7():174. PubMed ID: 27242548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human circadian clock and aging.
    Hofman MA
    Chronobiol Int; 2000 May; 17(3):245-59. PubMed ID: 10841206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Living by the clock: the circadian pacemaker in older people.
    Hofman MA; Swaab DF
    Ageing Res Rev; 2006 Feb; 5(1):33-51. PubMed ID: 16126012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.
    Bellanti F; Iannelli G; Blonda M; Tamborra R; Villani R; Romano A; Calcagnini S; Mazzoccoli G; Vinciguerra M; Gaetani S; Giudetti AM; Vendemiale G; Cassano T; Serviddio G
    J Alzheimers Dis; 2017; 59(2):615-631. PubMed ID: 28671110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin regulates the phase of the rat suprachiasmatic circadian pacemaker in vitro only during the subjective day.
    Medanic M; Gillette MU
    J Physiol; 1992 May; 450():629-42. PubMed ID: 1432721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities.
    Coogan AN; Schutová B; Husung S; Furczyk K; Baune BT; Kropp P; Häßler F; Thome J
    Biol Psychiatry; 2013 Sep; 74(5):333-9. PubMed ID: 23273723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin rhythmicity: effect of age and Alzheimer's disease.
    Skene DJ; Swaab DF
    Exp Gerontol; 2003; 38(1-2):199-206. PubMed ID: 12543278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal tissue containing the suprachiasmatic nucleus restores multiple circadian rhythms in old rats.
    Li H; Satinoff E
    Am J Physiol; 1998 Dec; 275(6):R1735-44. PubMed ID: 9843862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aging selectively suppresses vasoactive intestinal peptide messenger RNA expression in the suprachiasmatic nucleus of the Syrian hamster.
    Duncan MJ; Herron JM; Hill SA
    Brain Res Mol Brain Res; 2001 Mar; 87(2):196-203. PubMed ID: 11245922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian rhythm of spontaneous neuronal activity in the suprachiasmatic nucleus of old hamster in vitro.
    Watanabe A; Shibata S; Watanabe S
    Brain Res; 1995 Oct; 695(2):237-9. PubMed ID: 8556336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.